Access to high-quality information on the Dutch drug market is essential. This allows healthcare providers, researchers, policymakers and pharmaceutical companies to use medicines optimally and efficiently. However, to bring this data together, sector parties in healthcare will have to be willing to actually share data, but this is where the shoe regularly wriggles.
Read the article below on Zorgvisie.nl for more information.
Waarom is data delen zo moeilijk? - Zorgvisie